To Assess The Efficacy Of MadhusikthyÄ?di LepaAnd JÄ«vantayÄ?di Yamaka In Crack Heels.
- Conditions
- Health Condition 1: L86- Keratoderma in diseases classifiedelsewhere
- Registration Number
- CTRI/2021/01/030670
- Lead Sponsor
- ational Institute Of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1) Patient with the classical sign and symptoms of VipÄ?dikÄ? Kuá¹£á¹ha.
2) Patients 16 years to 70 years of age will be included.
3) Patients will be selected irrespective of sex, caste, occupation, socio- economic status.
4) Patients willing to participate in the study will be selected by explaining the interventions
in detail.
5) Patient willing to give written informed consent.
6) Patient willing to follow up.
1) The patient suffering from malignant systemic disorders, especially those are
mentioned as AsÄ?dhya VyÄ?dhi as per clinical text of Ä?yurveda will be excluded.
2) Patient with history of psoriasis.
3) Patient on some other medication.
4) Patient with VicarcikÄ? on foot.
5) Patient with other systemic disorders like DM etc.
6) Patient under other treatments of VipÄ?dikÄ?.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of MadhusikthyÄ?di Lepa and JÄ«vantayÄ?di Yamaka in the <br/ ><br>Management of VipÄ?dikÄ? in terms of change in Ã?yurvedic Symptom Score before and <br/ ><br>after intervention.Timepoint: 30 Days
- Secondary Outcome Measures
Name Time Method 1) To evaluate the efficacy of MadhusikthyÄ?di Lepa in the management of VipÄ?dikÄ?. <br/ ><br>2) To evaluate the efficacy of JÄ«vantayÄ?di Yamaka in the management of VipÄ?dikÄ?. <br/ ><br>3) To study the etiopathogenesis of VipÄ?dikÄ? Kuá¹£á¹ha. <br/ ><br>4) To assess the change in Dermatology Life Quality Index (DLQI) (Appendix 1)xi before <br/ ><br>and after interventionTimepoint: 30 Days